Abstract
Among different types of hematological cancer, acute lymphoblastic leukemia (ALL) is characterized by lymphoid progenitor cells bearing inherited genetic mutations and/or accumulated epigenetic alterations, affecting both T- and B-cell lineages, mainly during childhood. Genomic profiling has improved our understanding of the several pathways altered in ALL cells, and brought the cure rate…